<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.thepeptidenewsroom.com/pharmather-targets-colon-with-3d-printed-kpv-and-bpc-157-but-the-evidence-is-pre/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>PharmaTher Targets Colon With 3D-Printed KPV and BPC-157, But the Evidence Is Preclinical</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/oxycodone-linked-to-higher-gut-risk-than-hydrocodone-in-glp-1-users-large-claims/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>Oxycodone Linked to Higher Gut Risk Than Hydrocodone in GLP-1 Users, Large Claims Study Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/hhs-eases-enforcement-on-compounded-peptides-but-approval-is-not-what-changed/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>HHS Eases Enforcement on Compounded Peptides, But Approval Is Not What Changed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/collagen-peptides-what-the-research-shows-on-skin-wounds-and-blood-pressure/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>Collagen Peptides: What the Research Shows on Skin, Wounds and Blood Pressure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/bpc-157-use-rose-33-fold-in-clinical-records-but-the-evidence-has-not-followed/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>BPC-157 Use Rose 33-Fold in Clinical Records, But the Evidence Has Not Followed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/tb-500-just-got-easier-to-buy-in-the-us-but-its-human-evidence-is-nearly-nonexis/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>TB-500 Just Got Easier to Buy in the US, But Its Human Evidence Is Nearly Nonexistent</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/peptide-based-tube-feeds-no-better-than-standard-formulas-for-diarrhea-meta-anal/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>Peptide-Based Tube Feeds No Better Than Standard Formulas for Diarrhea, Meta-Analysis Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/hhs-opens-door-to-compounded-bpc-157-and-tb-500-but-safety-testing-stays-skipped/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>HHS Opens Door to Compounded BPC-157 and TB-500, But Safety Testing Stays Skipped</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/hhs-draft-policy-eases-enforcement-on-6-compounded-peptides-but-it-is-not-fda-ap/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>HHS Draft Policy Eases Enforcement on 6 Compounded Peptides, But It Is Not FDA Approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/fish-collagen-peptides-sped-wound-closure-in-diabetic-mice-but-no-patients-were-/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>Fish Collagen Peptides Sped Wound Closure in Diabetic Mice, But No Patients Were Tested</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/federal-policy-eases-up-on-compounded-bpc-157-but-the-first-trial-is-still-two-y/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31</news:publication_date>
      <news:title>Federal Policy Eases Up on Compounded BPC-157, But the First Trial Is Still Two Years Out</news:title>
    </news:news>
  </url>
</urlset>